Moleculin announces market assessment results for Annamycin in relapsed AML
Filed June 5, 2026 · Period ending June 5, 2026 · ~1 min read
1 material change detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade MBRX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 5, 2026 3:12 PM